Connect your AI

LivaNova LIVN Other Income (Expense)

Other Income (Expense) at other companies

HaemoneticsHAE

-$5.37M-799%

MedtronicMDT

$137M—

ITG

Integer HoldingsITGR

-$316K+99.3%

StrykerSYK

$62M-3.1%

Merit Medical SystemsMMSI

$9.39M+405%

TransMedics Group, Inc.TMDX

-$4.81M-527%

Other financials

Income statement

Revenue$362.3M+14.3%

Gross profit$243.7M+12.7%

Operating income$41.5M-14.7%

Net income$22.3M+107%

EPS (diluted)$0.40+107%

Balance sheet

Cash & equivalents$539.7M-26.9%

Total debt$340.9M-49.7%

Total equity$1.2B+17.1%

Total assets$2.5B-1.7%

Cash flow

Operating cash flow$15.2M-36.5%

CapEx$14.3M+32.4%

Free cash flow$926.0K-93.0%

Valuation

Market cap$4.32B+62.8%

Profitability

Gross margin67.5%-0.5pp

Operating margin13.4%+0.8pp

Net margin-16.1%-18.0pp

FCF margin11.2%-0.2pp

Returns & leverage

Return on equity-17.6%-19.5pp

Debt / equity0.3×-0.4×

Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is LivaNova's other income (expense)?: LivaNova (LIVN) reported other income (expense) of -$5.7M in Q1 2026.
How has LivaNova's other income (expense) changed year-over-year?: LivaNova's other income (expense) decreased by 149.9% year-over-year, from $11.42M to -$5.7M.
What is the long-term trend for LivaNova's other income (expense)?: Over 3 years (2022 to 2025), LivaNova's other income (expense) has grown at a 36.9% compound annual growth rate (CAGR), from $691K to $1.77M.
What does other income (expense) mean?: Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.